ConductScience.org, home

Paper · 35524263

Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations.

Tao LC and 4 others. Cardiovasc Diabetol, 2022. Cited by 819 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Papers, record 35524263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35524263

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations.
PubMed
Journal
Cardiovasc Diabetol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
819
iCite
Relative citation ratio, by iCite
78.8
iCite
Revised in PubMed
2022-07-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tao LCLi-Chan
2Xu JNJia-Ni
3Wang TTTing-Ting
4Hua FFei
5Li JJJian-Jun

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cardiovascular DiseasesMajor topic
Insulin ResistanceMajor topic
Biomarkers
Blood Glucose
Glucose
Humans
Risk Assessment
Risk Factors
Triglycerides

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References97

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132,919,465Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes.Cardiovasc Diabetol2020https://conductscience.org/library/papers/32919465PubMed
226,417,060Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014.Eur Heart J2015https://conductscience.org/library/papers/26417060PubMed
335,295,991Influence of the Triglyceride-Glucose Index on Adverse Cardiovascular and Cerebrovascular Events in Prediabetic Patients With Acute Coronary Syndrome.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/35295991PubMed
422,814,999Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease.Vasc Med2012https://conductscience.org/library/papers/22814999PubMed
532,156,279Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.Cardiovasc Diabetol2020https://conductscience.org/library/papers/32156279PubMed
634,991,602Evaluation of the long-term prognostic ability of triglyceride-glucose index for elderly acute coronary syndrome patients: a cohort study.Cardiovasc Diabetol2022https://conductscience.org/library/papers/34991602PubMed
734,689,767Association between the triglyceride glucose index and coronary collateralization in coronary artery disease patients with chronic total occlusion lesions.Lipids Health Dis2021https://conductscience.org/library/papers/34689767PubMed
833,812,901The prognostic value of the triglyceride glucose index in patients with chronic heart failure and type 2 diabetes: A retrospective cohort study.Diabetes Res Clin Pract2021https://conductscience.org/library/papers/33812901PubMed
934,183,007
Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.
Cardiovasc Diabetol2021https://conductscience.org/library/papers/34183007PubMed
1017,481,767Impact of mitochondrial ROS production in the pathogenesis of insulin resistance.Diabetes Res Clin Pract2007https://conductscience.org/library/papers/17481767PubMed

Cited by724

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 819 citations.

PMIDTitleJournalYearIn PapersSource
42,989,126Persistently elevated TyG index trajectories and all-cause mortality risk in elderly adults in southwestern China: a prospective cohort study.BMC Geriatr2026https://conductscience.org/library/papers/42989126PubMed
42,983,283Routine metabolic-adiposity indices and incident cardiometabolic multimorbidity among adults with CKM stages 0-3: a prospective cohort study.BMC Cardiovasc Disord2026https://conductscience.org/library/papers/42983283PubMed
42,964,174Study on the correlation between SPISE-IR, METs-IR, TyG and short-term adverse cardiovascular events in patients with heart failure and diabetes mellitus.Front Nutr2026https://conductscience.org/library/papers/42964174PubMed
42,958,172Preoperative triglyceride-glucose index and 30-day surgical site infection in OSCC patients without documented diabetes: a retrospective cohort study.BMC Oral Health2026https://conductscience.org/library/papers/42958172PubMed
42,952,496Glycemic biomarkers and cardiovascular disease in diabetes: a comparative analysis of population-based and clinical cohorts.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42952496PubMed
42,946,995
Association of the C-reactive protein-triglyceride-glucose index with adverse cardiovascular outcomes in patients with acute coronary syndrome and type 2 diabetes: findings from an observational cohort study in China.
BMC Cardiovasc Disord2026https://conductscience.org/library/papers/42946995PubMed
42,935,568Associations of the triglyceride-glucose index and intracranial arterial stenosis with poor functional outcome after ischemic stroke: a retrospective observational study of 712 patients.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42935568PubMed
42,933,839Prognostic value of the C-reactive protein-triglyceride-glucose index (CTI) for major adverse cardiovascular events in patients with coronary artery disease: a retrospective cohort study.BMJ Open2026https://conductscience.org/library/papers/42933839PubMed
42,921,267SPISE for predicting the presence of atrial fibrillation in patients with coronary artery disease: a comparative analysis with TyG index.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42921267PubMed
42,910,548Associations of the Baseline Level and Change in Triglyceride Glucose-Body Roundness Index With Cardiovascular Diseases: Two Large Prospective Cohorts in Europe and Asia.Kaohsiung J Med Sci2026https://conductscience.org/library/papers/42910548PubMed

1 to 10 of 724

See all 724 cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35524263

GET https://conductscience.org/api/papers/v1/35524263/references?page=2